MELINDA NOBLE: Open Payments
NPI 1477063568 · PALMER, AK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,341 in 44 payments from 11 companies in 2025. Trend: 2023 $1,289 · 2024 $1,369 · 2025 $1,341
Food & beverage: $1,341
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $270 |
| ABBVIE INC. | 7 | $267 |
| Amgen Inc. | 6 | $260 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $254 |
| Sumitomo Pharma America, Inc. | 4 | $86 |
| Lilly USA, LLC | 2 | $50 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $48 |
| GlaxoSmithKline, LLC. | 1 | $31 |
| Novartis Pharmaceuticals Corporation | 1 | $26 |
| PFIZER INC. | 1 | $25 |
Products named: CAPLYTA, EVENITY, VRAYLAR, AIRSUPRA, GEMTESA, BREZTRI, UBRELVY, MOUNJARO.
Industry payments across AK — which companies pay providers there.
